Summary
Microcomputers have been used in pharmacokinetics for several years, but their use in the area of formulation is a new application.
By using appropriate data on the drug, the dosage form required and its mechanism of absorption and clearance, microcomputers can systematize and speed-up formulation, simplify manufacturing processes and, through simulated models and plasma level predictions, reduce the number of bioavailability studies needed.
Similar content being viewed by others
References
Aiache J.-M., Devissaguet J.-P. and Guyot-Hermann A.-M. (1982): Galenica 2, Biopharmacie. 2ème Ed. Lavoisier, Paris.
Ritschel W.A. (1980): Handbook of basic pharmacokinetics. Drug Intelligence Publications, Hamilton.
Wagner J.-G. (1975): Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton.
Metzler CM. (1975): A user’s manual to ‘nonlin’. The Upjohn Company, Kalamazoo, Michigan.
Peck C.C. (1979): Non linear least- squares regression programs for microcomputers. J. Pharmacokin. Biopharm.,7(5), 537–541.
Koeppe P. (1980): A program for non linear regression analysis to be used on desk-top computers. Computer programs in Biomedicine,12, 121–128.
Riegelman S. and Upton R.A. (1979): In vitro and in vivo bioavailability correlation. Drug Absorption, Prescott L.F. and Nimmo W.S. Ed.,2, 297.
Guitard P. (1980): Simulation du niveau plasmatique donné par une forme à action prolongée. Cas d’une ciné tique de dissolution quelconque. 2ème Congrès international de technologie pharmaceutique. APGI Paris 3–5 juin 1980, 219.
Steinbach D., Thoma K., Moeller H. and Stenzhorn G. (1980): Evaluation of pharmaceutical availability from the calculation of drug levels and release profiles. Int. J. Pharm.,4, 327.
Moeller H. (1981): Comparative evaluation ofin vitro andin vivo drug release of depot preparation. 1er Congrès Européen de biopharmacie et pharmacocinétique. Clermont-Ferrand, Avril 1981, Ed. Lavpoisier, Paris.
Guerten D. et Jaminet F. (1981): Méthode générale de simulation des taux sanguins à partir de données de dissolution: une dose unique. Pharma. Acta Helv.,56, 276.
Guerten D. et Jaminet F. (1981): Méthode générale de simulation des taux sanguins à partir de données de dissolution: doses multiples. Pharma. Acta Helv.,56, 314.
Riegelman S. and Collier P. (1980): The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption time. J. Pharmacokin. Biopharm.,8, 509.
Nelson E. (1957): A note on mathematics of oral sustained release products. J. Amer. Pharm. Assoc. (Sci. Ed),46, 572.
Himmelblau D.M. (1972): Applied non linear programming. MacGraw Hill, New York.
Wiegand R.G. and Taylor J.D. (1960): Kinetics of plasma drug levels after sustained release dosage. Biochem. Pharmacol.,3, 256.
Wagner J.G. (1974): Application of the Wagner-Nelson absorption method to the two-compartment open model. J. Pharmacokin. Biopharm.,2, 469.
Robinson J.R. and Erikson S.P. (1966): Theoretical formulation of sustained release dosage forms. J. Pharm. Sci.,55, 1254.
Aiache J.-M. et Dubray M. (1981): Formulation et ordinateur. Bulletin Technique Gattefossé, 13.
Guerten D., Dresse A. et Jaminet F. (1981): Profil de dissolution et prévision des taux sanguins d’une forme à action prolongée de theophylline. Comparaison avec des résultatsin vivo. 1 er Congrès Européen de biopharmacie et pharmacocinétique. Clermont-Ferrand. Avril 1981, Ed. Lavoisier, Paris.
Kaplan S.A. and Jack M.L. (1980): Pharmacokinetics as a tool in drug development. Progress in Drug Metabolism,4, 1.
Thebault J.-J., Aiache J.-M., Darbeau D. and Le Bastard B. (1981): Bioavailability of a long lasting formulation of dihydroergotamine in man. 1 er Congrès Européen de biopharmacie et pharmacocinétique. Clermont-Ferrand. Avril 1981, Ed. Lavoisier, Paris.
Aiache J.-M., Pradat S. et Pognat J.-F. (1981): Influence du méthyl-sulfate de tiemonium sur l’absorption gastrointestinale d l’aspirine. 1er Congrès Européen de biopharmacie et pharmacocinétique. rmont-Ferrand. Avril 1981, Ed. Lavoisier, Paris.
Langenbucher F. (1982): Numerical convolution/deconvolution as a tool for correlatingin vitro within vivo drug availability. Pharm. Ind.,44(11), 1166–1172.
Bindschaedler C. and Gurny R. (1982): Optimisation de formulations pharmaceutiques par la méthode du Simplex au moyen d’une calculatrice TI 59. Pharm. Acta Halv.,57(9), 251–255.
Author information
Authors and Affiliations
Additional information
Plenary lecture at the 3rd International Symposium on Biopharmaceutics and Pharmacokinetics, 1982, Strebske Plezo, Czechoslovakia.
Rights and permissions
About this article
Cite this article
Aiache, J.M., Turlier, M. & Tanguy, A. Pharmacokinetic data processed by microcomputer for the formulation of optimal drug dosage form. European Journal of Drug Metabolism and Pharmacokinetics 9, 89–102 (1984). https://doi.org/10.1007/BF03189611
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189611